Gelest, Inc. (Booth #504) is highlighting its silicon-based BIOSAFE® antimicrobial, which it recently acquired after a two-year period of exclusive licensing. Gelest is now shepherding the product through Food Contact approvals from the U.S. FDA and EPA.
Today through June 4 in Atlantic City, N.J, Gelest, Inc. is highlighting silicon-based BIOSAFE® antimicrobials for long-lasting surface protection and advanced silanes for high- performance applications. Gelest’s dipodal silanes improve substrate bonding, and its cyclic azasilanes provide effective surface modification at nanodimensions.
At NPE 2015, Gelest, Inc. is highlighting its silicon-based BIOSAFE® antimicrobials for long-lasting surface protection, dipodal silanes to improve substrate bonding, cyclic azasilanes for treating fillers in nanocomposites, and functional and inert silicone fluids for polymer synthesis, internal lubricants and flow control.